Content continues after advertisement

Avoiding Pet Owner Burnout When Treating Canine Skin Disease

Katherine Doerr, DVM, DACVD, Veterinary Dermatology Center, Maitland, Florida

Dermatology

|November/December 2021

Sign in to Print/View PDF

In the Literature

Spitznagel MB, Hillier A, Gober M, Carlson MD. Treatment complexity and caregiver burden are linked in owners of dogs with allergic/atopic dermatitis. Vet Dermatol. 2021;32(2):192-e50.


FROM THE PAGE …

Chronic allergic dermatitis in dogs can result in significant caregiver burden for pet owners. A previously published report1 discussed the positive correlation between caregiver burden and severity of canine skin disease. 

The goal of the current study was to relate caregiver burden to both objective and subjective treatment complexity. Eighty-six participants were enrolled after completing an online survey about their dog with skin disease. An adapted 18-item Zarit Burden Interview validated for companion animal owners was used to assess caregiver burden, and a previously published measure was used to determine severity of skin disease. Complexity of treatment plans was subjectively determined using statements from the Pet Owner Adherence Scale. To decrease the influence of owner perception of difficulty, objective treatment complexity was determined by requesting the specific number of individual treatments required for management. 

A majority (ie, >80%) of enrolled dogs had moderate to severe skin disease that was positively correlated with caregiver burden. In addition, caregiver burden increased as the owner’s subjective assessment of treatment complexity increased, independent of disease severity. Objective analysis of treatment complexity was also positively correlated with the degree of caregiver burden.

Assessing caregiver burden is vital for successful management of dogs with allergic dermatitis. It is important to understand that as treatment complexity increases, compliance may decrease due to caregiver burden. Burden transfer to the clinician, in which owners overburdened with caregiving transfer their stress to the clinician, may also increase if the owner does not feel they can complete the treatments recommended for their dog.2 Although multimodal therapy is paramount in the treatment of allergic dermatitis, starting with a simple, yet effective, treatment plan can yield lower caregiver burden.


… TO YOUR PATIENTS

Key pearls to put into practice:

1

Simple, effective treatment plans should be chosen, if possible, for dogs with skin disease. Additional therapies may be provided once the patient is comfortable, but caregiver burden should be assessed at each examination.

2

Compliance may be increased by limiting the number of treatment modalities and initially focusing on the most effective therapies.

 

3

Simplistic treatment plans may also decrease burden transfer to clinicians, as caregiver burden would decrease, potentially resulting in fewer treatment-related follow-up questions or confusion.

References

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast

Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Privacy Policy (Updated 01/07/2022) Acceptable Use Policy (Updated 11/22/2021)